Prosthetic Joint Infection from Carbapenemase-Resistant Klebsiella pneumoniae Successfully Treated with Ceftazidime-Avibactam

被引：13
|
作者：
Schimmenti, A. [1 ]
Brunetti, E. [1 ,2 ]
Seminari, E. [2 ]
Mariani, B. [3 ]
Cambieri, P. [3 ]
Orsolini, P. [2 ,4 ]
机构：
[1] Univ Pavia, Unita Malattie Infett & Trop Epatol, Dipartimento Sci Clinicochirurg & Diagnost & Pedi, Pavia, Italy
[2] Fdn IRCCS Policlin San Matteo, Unita Malattie Infett & Trop, Pavia, Italy
[3] Fdn IRCCS Policlin San Matteo, Microbiol & Virol, Pavia, Italy
[4] Univ Pavia, Dipartimento Med Interna & Terapia Med, Pavia, Italy
来源：
CASE REPORTS IN INFECTIOUS DISEASES | 2018年 / 2018卷
关键词：
D O I：
10.1155/2018/1854805
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Antimicrobial resistance in Gram-negative bacteria, particularly Enterobacteriaceae, has become a leading cause of morbidity and mortality and a serious public health concern. Gram-negative bacteria carrying extended-spectrum beta-lactamase (ESBL) enzymes now represent a significant proportion of all bacteria isolated from different countries worldwide. Furthermore, the increasing number of isolates carrying carbapenemases in recent years includes multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) bacteria. Here, we describe what, to our knowledge, is the first case of a patient with a prosthetic joint infection from carbapenemase-resistant Klebsiella pneumoniae (CRKP) successfully treated with ceftazidime-avibactam in Italy.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Ceftazidime-avibactam activity against Escherichia coli and Klebsiella pneumoniae
    Sachu, Arun
    David, Alice
    IRANIAN JOURNAL OF MICROBIOLOGY, 2025, 17 (01) : 19 - 24
  • [22] Ceftazidime-avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae
    Lima, O.
    Sousa, A.
    Longueira-Suarez, R.
    Filgueira, A.
    Taboada-Martinez, C.
    Portela-Pino, C.
    Nodar, A.
    Vasallo-Vidal, F.
    Martinez-Lamas, L.
    Perez-Landeiro, A.
    Rubianes, M.
    Perez-Rodriguez, M. T.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (09) : 1173 - 1182
  • [23] Successful Treatment of Pandrug-resistant Klebsiella pneumoniae Infection With Ceftazidime-avibactam in a Preterm Infant A Case Report
    Coskun, Yesim
    Atici, Serkan
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (09) : 854 - 856
  • [24] Minimum inhibitory concentrations of aztreonam-avibactam, ceftazidime-avibactam and meropenem in clinical isolates of Klebsiella pneumoniae harboring carbapenemase genes
    Ageevets, Vladimir
    Sulian, Ofelia
    Avdeeva, Alisa
    Chulkova, Polina
    Ageevets, Irina
    Gostev, Vladimir
    Alieva, Kamilla
    Golikova, Maria
    Sidorenko, Sergey
    JOURNAL OF ANTIBIOTICS, 2024, 77 (10): : 706 - 710
  • [25] In Vitro Activity of Ceftazidime-Avibactam against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates
    Yu, Fangyou
    Lv, Jingnan
    Niu, Siqiang
    Du, Hong
    Tang, Yi-Wei
    Bonomo, Robert A.
    Kreiswirth, Barry N.
    Chen, Liang
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (08)
  • [26] Ceftazidime-Avibactam for Hospital Acquired Pneumonia Due to Extended Drug-Resistant Klebsiella pneumoniae
    Amit Ranjan Rup
    Arun Kumar Dash
    Sibabratta Patnaik
    The Indian Journal of Pediatrics, 2021, 88 : 290 - 291
  • [27] Ceftazidime-Avibactam for Hospital Acquired Pneumonia Due to Extended Drug-Resistant Klebsiella pneumoniae
    Rup, Amit Ranjan
    Dash, Arun Kumar
    Patnaik, Sibabratta
    INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (03): : 290 - 291
  • [28] Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella pneumoniae
    Ojdana, Dominika
    Gutowska, Anna
    Sacha, Pawel
    Majewski, Piotr
    Wieczorek, Piotr
    Tryniszewska, Elzbieta
    MICROBIAL DRUG RESISTANCE, 2019, 25 (09) : 1357 - 1364
  • [29] In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam/ aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India
    Borde, Kalyani
    Kareem, M. A.
    Sharma, Ratna Mani
    Dass, S. Manick
    Ravi, Vedantham
    Mathai, Dilip
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [30] Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant Klebsiella pneumoniae
    Wu, Yun
    Yu, Wei
    Chu, Xiaobing
    Zhang, Jingjia
    Jia, Peiyao
    Liu, Xiaoyu
    Zhu, Ying
    Xu, Yingchun
    Yang, Qiwen
    MICROBIOLOGY SPECTRUM, 2024, 12 (06):
12345